New Delhi: Pharmaceuticals firm Lupin Ltd. said its US-based arm is recalling four lots of Quinapril tablets used to treat high blood pressure due to the presence of a nitrosamine impurity. 

Lupin Pharmaceuticals Inc., the company's wholly-owned arm, is recalling the tablets due to the presence of a nitrosamine impurity, N-Nitroso-Quinapril, observed in recent testing above the acceptable daily intake (ADI) level, Lupin Ltd. said in a regulatory filing.

Click for more on Drug recall

"To date, Lupin has received no reports of illness that appear to be related to this issue," it said, adding that Quinapril tablets would be discontinued in September 2022.

Quinapril tablets of strengths 20 mg and 40 mg, packaged in separate 90 count bottles, were distributed nationwide in the US to wholesalers, drug chains, mail order pharmacies, and supermarkets, it added.

The filing further said Lupin Pharmaceuticals Inc. is notifying its wholesalers, distributors, drug chains, mail order pharmacies, and supermarkets by phone and through recall notification and is arranging for the return of all the recalled product lots while asking them to discontinue distribution of the recalled lots immediately.

Click for more articles on Lupin Pharmaceuticals

The company, however, advised patients taking the Quinapril tablets "to continue taking their medication and contact their pharmacist, physician, or medical provider for advice regarding an alternative treatment."

"This recall is being conducted with the knowledge of the US Food and Drug Administration," it added. The company said nitrosamines are common in water and foods, including cured and grilled meats, dairy products, and vegetables.

While everyone is exposed to some level of nitrosamines, these impurities may increase the risk of cancer if people are exposed to them above acceptable levels over long periods of time, it added.

Drug recall: Sodium Bicarbonate Injection recalled due to this reason

Drug recall: Dr Reddy’s, Sun Pharma recall these drugs due to this reason

Drug recall: FDA issues nationwide recall for Ferric Carboxymaltose

Drug recall: These drugs recalled by Aurobindo for this reason

Drug recall: These products recalled by Dr Reddy’s, Cipla, and Aurobindo

Drug recall: Sodium Bicarbonate Injection recalled due to this reason

USFDA gives approval for Pregabalin capsules

Kerala to cancel licences of Medical Stores selling antibiotics without prescription

USFDA gives approval for Brivaracetam Tablets

NPPA fixes Retail Price of 12 scheduled formulations: December 2022

NPPA revises Retail Price of 107 scheduled formulations: December 2022

NABL asks Testing Laboratories to get product based accreditation

Goa FDA allows manufacture and marketing of Ulipristal Acetate Tablets 5mg

DCOIWA: Workshop on Medical Device Regulation and Legal Documentation organized

Bulk transfer of Blood and Blood Components: Procedure and Conditions

Latest Notifications regarding Pharmaceuticals
https://thehealthmaster.com/2022/12/23/drug-recall-this-blood-pressure-tablets-recalled/